Consultation services for biological therapeutics development
Official title: Biological Therapeutics consultation services
Funded at Neuimmune Biologics, INC. · NIH-11199848 · Data updated 2026-11-12
This study is all about helping scientists create better biological treatments for different health conditions by providing expert advice, which could ultimately lead to more effective therapies for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Neuimmune Biologics, INC. NIH-funded |
| Lab location | 1 site (Sykesville, United States) |
| Project start | July 10, 2024 |
| Project end | July 9, 2025 |
| Funding year | 2024 |
| Award (this year) | $10,000 |
| NIH project number | 75N95A24P00092-0-0-1 |
| Project ID | NIH-11199848 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are patients with neurological disorders who may be treated with biologic therapies.
✕Less likely to help
Patients with conditions not addressed by biological therapeutics or those not involved in the NIH Blueprint Neurotherapeutics Network may not receive any benefit.
What this research studies
This research focuses on providing expert consultation services to enhance the development of biological therapeutics within the NIH Blueprint Neurotherapeutics Network. Experienced professionals will offer strategic guidance and technical feedback on drug discovery and development projects, ensuring that the programs are effectively managed and aligned with best practices. Patients may benefit indirectly as these consultations aim to improve the quality and efficacy of biologic treatments being developed for various conditions.
Why it matters
Potential benefit: If successful, this research could lead to more effective biological therapies for patients with neurological conditions.
How similar studies have gone: While this approach is focused on consultation services, similar initiatives in drug development have shown success in improving therapeutic outcomes.
Where this research is happening
-
Neuimmune Biologics, INC.
Sykesville, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Developing a vaccine to combat Hepatitis C virus
This study is working on a new vaccine for Hepatitis C that uses a special part of the virus to help your body build a strong defense against it, which could lead to a more effective and reliable way to protect people from the virus.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.